EP4116325

METHODS OF TREATING RHEUMATOID ARTHRITIS USING IL-17 ANTAGONISTS

  • Status:
    EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi
  • EP appl. date:
    4.11.2011
  • EP published:
    1.4.2026
  • EP application number:
    22180976.7
  • Max expiry date:
    3.11.2031
  • Expiry date:
    3.11.2026
  • Title in English:
    METHODS OF TREATING RHEUMATOID ARTHRITIS USING IL-17 ANTAGONISTS
  • Language of the patent:
    English

Timeline

Today
4.11.2011EP application
1.4.2026EP Publication
3.11.2026Expires

Owner

  • Name:
    Novartis AG
  • Address:
    Lichtstrasse 35, 4056 Basel, CH

Inventor

  • Name:
    MPOFU, Shepard
  • Address:
    4002 Basel, CH
  • Name:
    RICHARDS, Hanno
  • Address:
    4002 Basel, CH
  • Name:
    THANGAVELU, Karthinathan
  • Address:
    4002 Basel, CH
  • Name:
    MACHACEK, Matthias
  • Address:
    4002 Basel, CH

Priority

  • Number:
    41053310 P
  • Date:
    5.11.2010
  • Country:
    US

Classification

  • Categories:
    C07K 16/24, A61K 39/395, A61P 37/02

Upload documents